| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 10/05/2005 | CN1221665C Use of negative regulation elements for nerve-specific expression of transgenes |
| 10/05/2005 | CN1221274C Medicine with acupuncture and moxibustion effect of stimulating main collateral channels and acupuncture point and its preparation method |
| 10/05/2005 | CN1221271C Chinese medicinal external preparation for treating ulcer of lower limbs |
| 10/05/2005 | CN1221269C Paralysis treating medicine pills |
| 10/04/2005 | US6951923 For regenerating tissues; antiaging agents; medical diagnosis; monitoring chemotherapy |
| 10/04/2005 | US6951658 administering mixtures of animal oils, lioleic acid, arginine, pyroglutamic acid, methyl vitamin B12 and calcium, for prophylaxis of neurodegenative diseases |
| 09/30/2005 | CA2462404A1 Amplification of t cells from human cord blood in serum-deprived culture stimulated with stem cell factor, interleukin-7 and interleukin-2 |
| 09/29/2005 | WO2005090574A1 Vascular endothelial growth inhibiting gene |
| 09/29/2005 | WO2005090558A1 Method for making high purity cardiomyocyte preparations suitable for regenerative medicine |
| 09/29/2005 | WO2005090556A1 Novel method of acquiring/sustaining stem cell/precursor cell |
| 09/29/2005 | WO2005090368A1 Synthetic membrane anchors |
| 09/29/2005 | WO2005089823A1 Settling agent for hollow organ to be regenerated, hollow organ to be regenerated of settling type, method of constructing hollow organ to be regenerated of settling type and method of regenerating and settling hollow organ |
| 09/29/2005 | WO2005089787A1 Use of poly-glu,tyr for treatment of stroke and other disorders |
| 09/29/2005 | WO2005089781A1 Method of preventing nodavirus infection and therapeutic method |
| 09/29/2005 | WO2005089420A2 Expansion of neural stem cells with lif |
| 09/29/2005 | WO2005089411A2 Tissue products from animals lacking functional alpha 1,3 galactosyl transferase |
| 09/29/2005 | WO2005089127A2 Polymer-ceramic-hydrogel composite scaffold for osteochondral repair |
| 09/29/2005 | WO2005072477A3 Method for the separation of phospholipids from phospholipid-containing materials |
| 09/29/2005 | WO2005063801A3 Method for decreasing the contact between hepta-repeat region s of the corona-virus spike proteins and use thereof |
| 09/29/2005 | WO2005058241A3 Child's cleaning implement comprising a biological extract |
| 09/29/2005 | WO2005042730A3 Method and system for preparing stem cells from fat tissue |
| 09/29/2005 | WO2005003335A9 Rapamycin resistant t cells and therapeutic uses thereof |
| 09/29/2005 | WO2004014314A3 Methods and compositions concerning poxviruses and cancer |
| 09/29/2005 | WO2003074057A8 Anti-infective agents and/or immunomodulators used for preventive therapy following an acute cerebrovascular accident |
| 09/29/2005 | US20050216964 Using swine organs devoid of porcine endogenous retrovirus (PERV) for xenotransplantation and treatment of end-stage organ diseases |
| 09/29/2005 | US20050215850 Syringe pump |
| 09/29/2005 | US20050215803 Method for the separation of phospholipids from phospholipid-containing materials |
| 09/29/2005 | US20050215722 Drug delivery compositions and medical devices containing block copolymer |
| 09/29/2005 | US20050215502 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 09/29/2005 | US20050215496 Preparation and diabetic use of Gibberellins |
| 09/29/2005 | US20050215471 Compositions of bacteria and alpha-lactalbumin and uses thereof |
| 09/29/2005 | US20050215469 Reducing food intake; obesity; dietetics |
| 09/29/2005 | US20050214942 Activation and expansion of cells |
| 09/29/2005 | US20050214941 Expansion of neural stem cells with LIF |
| 09/29/2005 | US20050214940 Nervous system progenitor cell culure for use in treatment and prevention neural degenerative, spinal cord and brain disorders |
| 09/29/2005 | US20050214733 Sperm suspensions for use in insemination |
| 09/29/2005 | US20050214381 Method for improvement and modulation of humane immune response through supplementation of colostrum |
| 09/29/2005 | US20050214300 Methods for treating cancer using Porimin as a target |
| 09/29/2005 | US20050214274 T-cells are contacted agents that ligate a cell surface; crosslinking by a second agent attached to a biodegradable supports; T-cells and biodegradable supports are suspended in a medium for parenteral infusion and packaged in container |
| 09/29/2005 | US20050214273 Propionibacterium P-63 for use in direct fed microbials for animal feeds |
| 09/29/2005 | US20050214272 Antiinflammatory agents for gastrointestinal inflammation involved with inflammatory bowel disease or irritable bowel syndrome |
| 09/29/2005 | US20050214270 Lactobacillus acidophilus and/or fermentum; reducing immunoglobulin E levels; safe, easy to take |
| 09/29/2005 | US20050214269 Induction of beta cell differentiation in human cells |
| 09/29/2005 | US20050214266 Pretreating hematopoietic stem cells harvested from blood or bone marrow, tissue materials and/or organs prior to surgical implantation; preventing infections |
| 09/29/2005 | US20050214262 Population of hematopoietic cells, made to exhibit a greater clonogenic potential, engraftment potential, immune system reconstitution potential and/or proportion of CD34+ positive cells by culturing with a transition metal compound that chelates copper such as tetraethylenepentamine |
| 09/29/2005 | US20050214257 Using self assembling peptide amphiphiles in organ or tissue transplant materials |
| 09/29/2005 | US20050214242 Compositions containing internally activated antioxidant |
| 09/29/2005 | DE202005010821U1 Piece of soap contains stone(s), e.g. healing stones such as orange carnelian or green aventurine in translucent or clear, optionally scented soap |
| 09/29/2005 | CA2560300A1 Method of preventing nodavirus infection and therapeutic method |
| 09/29/2005 | CA2559969A1 Streptococcus agalactiae vaccine |
| 09/29/2005 | CA2559854A1 Method for making high purity cardiomyocyte preparations suitable for regenerative medicine |
| 09/29/2005 | CA2559721A1 Expansion of neural stem cells with lif |
| 09/29/2005 | CA2559720A1 Tissue products derived from animals lacking any expression of functional alpha 1,3 galactosyltransferase |
| 09/29/2005 | CA2559662A1 Novel antibiotic alternatives |
| 09/29/2005 | CA2557436A1 Polymer-ceramic-hydrogel composite scaffold for osteochondral repair |
| 09/28/2005 | EP1580272A2 TAT transdominant variants of human immunodeficiency virus (HIV) |
| 09/28/2005 | EP1579865A1 Means for preventing and curing endocrine system disturbances |
| 09/28/2005 | EP1578983A2 Methods for regulating co-stimulatory molecule expression with reactive oxygen |
| 09/28/2005 | EP1578958A2 Method for suppressing immune system response to transplanted tissue or cells |
| 09/28/2005 | EP1578926A2 Novel prostate tumor-specific promoter |
| 09/28/2005 | EP1578925A2 Methods for in vitro expansion and transdifferentiation of human pancreatic acinar cells into insulin-producing cells |
| 09/28/2005 | EP1578924A2 Genomic screen for epigenetically silenced tumor suppressor genes |
| 09/28/2005 | EP1578897A2 Process for inducing functional tolerance to gene transfer products |
| 09/28/2005 | EP1578459A2 Apparatus and method for immunotherapy of a cancer through controlled cell lysis |
| 09/28/2005 | EP1578451A2 Treating carcinoid neoplasms with therapeuthic viruses |
| 09/28/2005 | EP1578396A2 Methods and compositions concerning poxviruses and cancer |
| 09/28/2005 | EP1578380A2 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 09/28/2005 | EP1578211A2 Kolla 2-desiccated avian sternal cartilage powder |
| 09/28/2005 | EP1578200A1 Cell-based vegf delivery |
| 09/28/2005 | EP1465489A4 Methods of expressing lim mineralization protein in non-osseous cells |
| 09/28/2005 | EP1356277A4 Method for altering cell fate |
| 09/28/2005 | EP1137766B1 Use of il-12 antibodies to treat psoriasis |
| 09/28/2005 | EP0991763B1 Modified adenoviral fiber and target adenoviruses |
| 09/28/2005 | CN1675542A Isolation and identification of T cells |
| 09/28/2005 | CN1675354A In vitro fertilisation |
| 09/28/2005 | CN1674932A Novel bacterium for treatment of disease |
| 09/28/2005 | CN1673361A Multipotential cell containing heterogenous nuclear and mitochondrion |
| 09/28/2005 | CN1673352A A novel bacillus and separating process and application |
| 09/28/2005 | CN1672692A Naoxuekang dripping pill and its prepn process |
| 09/28/2005 | CN1672691A Prepn of squid ink extract and its application in making medicine and food for preventing and treating human tumor |
| 09/28/2005 | CN1672690A Shengu dispersive tablet and its prepn process |
| 09/28/2005 | CN1220766C Health preserving wine |
| 09/28/2005 | CN1220764C Health care wine |
| 09/28/2005 | CN1220517C Medication for curing disease of stomach intestine |
| 09/28/2005 | CN1220514C Preparation of Chinese patent medicine for treating hyperplasia of mammary glands |
| 09/28/2005 | CN1220512C Capsule with pilose deerhorn blood and gingeng and its preparation method |
| 09/28/2005 | CN1220510C Chinese patent medicine with the functions of replenishing qi and blood and nourishing the heart to calm the mind, its preparation method and quality control method |
| 09/28/2005 | CN1220509C Chinese patent medicine for curing cardiovascular disease, its preparation method and quality control method |
| 09/28/2005 | CN1220499C Kidney-invigorating and Yang-strengthening wine |
| 09/28/2005 | CN1220498C Medicament for treating asthma |
| 09/28/2005 | CN1220497C Antivirus antioxidizing active extract of proplis and its molecular clathrate compound preparation |
| 09/27/2005 | US6949586 Synergistic composition of trans-tetracos-15-enoic acid and Apocynin and method of treatment for hepatotoxicity |
| 09/27/2005 | US6949381 Immortalized human skin cell lines and novel serum-free medium useful for the production thereof |
| 09/27/2005 | US6949380 culturing a proliferating epidermal basal cell population, exposing the cell(s) to fetuin, noggin, chordin, gremlin, follistatin, growing the cell(s) in the presence of an antisense oligonucleotide antagonist of bone morphogenetic protein (BMP) |
| 09/27/2005 | US6949361 Polynucleotide |
| 09/27/2005 | US6949252 Method for preparing an implantable multilayer tissue construct |
| 09/27/2005 | US6949249 Mixture contains flow control agent and thickener |
| 09/27/2005 | CA2428206C Methods for the treatment of cellular proliferative disorders |
| 09/27/2005 | CA2217298C Method for the microbial decontamination of blood platelets |
| 09/27/2005 | CA2108104C Fibrin sealant compositions and methods for utilizing same |